AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vildamac M 50/850 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Vildamac M 50/850 Tablet

Combivir M 50/850 tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially decreasing the risk of cardiovascular events such as stroke or myocardial infarction. Combivir M 50/850 may be administered independently or in conjunction with other anti-diabetic therapies. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation reduces the likelihood of future serious health problems. Maintaining the prescribed dietary and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal distress, cephalalgia, pharyngitis, asthenia, gastroesophageal reflux, diaphoresis, and anorexia. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its potential to decrease blood glucose. Your doctor will monitor your renal function and blood sugar levels regularly throughout your treatment.

Uses of Vildamac M 50/850 Tablet

Managing type 2 diabetes

Major Benefits of Vildamac M 50/850 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vildamac M 50/850 Tablet with a meal.

Common Side effects of Vildamac M 50/850 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildamac M 50/850 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildamac M 50/850 Tablet with a meal.

How Vildamac M 50/850 Tablet works:

Vildamac M 50/850 tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Vildamac M 50/850 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vildamac M 50/850 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildamac M 50/850 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildamac M 50/850 tablets, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Vildamac M 50/850 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildamac M 50/850 Tablet :

Should you forget a Vildamac M 50/850 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildamac M 50/850 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildamac M 50/850 Tablet

Vildamac M 50/850 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildamac M 50/850 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always discuss taking any other medication with your doctor.
Vildamac M 50/850 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildamac M 50/850 Tablet combines metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildamac M 50/850 Tablet can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect, linked to metformin, necessitates avoidance in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildamac M 50/850 Tablet and seek immediate medical attention.
Prolonged Vildamac M 50/850 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildamac M 50/850 Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (especially if also taking insulin or sulphonylurea). Report any persistent issues to your physician.
Vildamac M 50/850 Tablet
134
MRP 155
13% off